Simultaneous immunochemical detection of stanozolol and the main human metabolite, 3′-hydroxy-stanozolol, in urine and serum samples

Analytical Biochemistry

Volumn 376, Issue 2, 2008, Pages 221-228

  Salvador, J Pablo ^a   Sánchez Baeza, Francisco ^a   Marco, M Pilar ^a  

^a CSIC   (Spain)

Author keywords

3 hydroxy stanozolol; Doping; ELISA; Hapten; Plasma; Stanozolol; Urine

Indexed keywords

ANTIGENS; BIOMOLECULES; DOPING (ADDITIVES); PLASMAS;

BIOLOGICAL SAMPLES; ELISA; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPTEN; IMMUNOREACTIVITIES; STANOZOLOL; URINE; WORLD ANTI-DOPING AGENCY;

METABOLITES;

3' HYDROXYSTANOZOLOL; ANTIGEN; ANTISERUM; HAPTEN; N2' (5 VALERIC ACID)ANDROST 2 ENO[3,2 C]PYRAZOL 17A METHYL 17B OL; STANOZOLOL; UNCLASSIFIED DRUG;

ARTICLE; ATHLETE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IC 50; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; METABOLITE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; THEORETICAL STUDY; URINALYSIS;

EID: 41949129282     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.02.009     Document Type: Article

References (17)

1. Poelmans S., De Wasch K., De Brabander H.F., Van De Wiele M., Courtheyn D., van Ginkel L.A., Sterk S.S., Delahaut P., Dubois M., and Schilt R. Analytical possibilities for the detection of stanozolol and its metabolites. Analytica Chimica Acta 473 (2002) 39-47
2. WADA, The 2006 Prohibited list. International Standard, http://www.wada-ama.org/en/dynamic.ch2?pageCategory_id=47, World Anti-Doping Agency 2006.
3. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg, Monitoring the Future national results on adolescent drug use: Overview of key findings. 2005, National Institute on Drug Abuse. National Institutes of Health. U.S. Department of Health and Human Services, Bethesda, Maryland, 2006, pp. 79 pp.
4. Cafri G., van den Berg P., and Thompson J.K. Pursuit of muscularity in adolescent boys: Relations among biopsychosocial variables and clinical outcomes. J. Clin. Child Adolescent Psychol. 35 (2006) 283-291
5. Miller K.E., Hoffman J.H., Barnes G.M., Sabo D., Melnick M.J., and Farrell M.P. Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Substance Use Misuse 40 (2005) 1637-1657
6. Dickinson B., Goldberg L., Elliot D., Spratt D., Rogol A.D., and Fish L.H. Hormone abuse in adolescents and adults - A review of current knowledge. Endocrinologist 15 (2005) 115-125
7. Cafri G., Thompson J.K., Ricciardelli L., McCabe M., Smolak L., and Yesalis C. Pursuit of the muscular ideal: Physical and psychological consequences and putative risk factors. Clin. Psychol. Rev. 25 (2005) 215-239
8. De Brabander H.F., De Wasch K., van Ginkel L.A., Sterk S.S., Blokland M.H., Delahaut P., Taillieu X., Dubois M., Arts C.J.M., van Baak M.J., Gramberg L.G., Witkamp R.F., Schilt R., van Bennekom E.O., Courtheyn D., and Vercammen J. Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves. Analyst (Cambridge U. K.) 123 (1998) 2599-2604
9. Schaenzer W., Delahaut P., Geyer H., Machnik M., and Horning S. Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry. J. Chromatogr. B (1996) 93-108
10. Delahaut P., Taillieu X., Dubois M., De Wasch K., De Brabander H.F., and Courtheyn D. Detection of stanozolol metabolites in bovine urine after intramuscular injection. Arch. Lebensmittelhyg. 49 (1998) 3-7
11. Leinonen A., Kuuranne T., Kotiaho T., and Kostiainen R. Screening of free 17-alkyl-substituted anabolic steroids in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 69 (2004) 101-109
12. Estévez M.C., Galve R., Sánchez-Baeza F., and Marco M.-P. A Direct Competitive Enzyme-Linked Immunosorbent Assay (ELISA) for the Determination of the Highly Polar Short Chain SulfophenylCarboxylates (SPC). Anal. Chem. 77 (2005) 5283-5293
13. Estevez M.-C., Kreuzer M., Sanchez-Baeza F., and Marco M.-P. Analysis of Nonylphenol: Advances and Improvements in the Immunochemical Determination Using Antibodies Raised against the Technical Mixture and Hydrophilic Immunoreagents. Environ. Sci. Technol. 40 (2006) 559-568
14. Carlson R.E. Hapten verus competitor design strategies for immunoassay development. In: Nelson J.O., Karu A.E., and Wong R.B. (Eds). Immunoanalysis for agrochemicals (1995), Americah Chemical Society, Washington DC 141-152
15. Wie S.I., and Hammock B.D. Comparison of coating and immunizing antigen structure on the sensitivity and specificity of immunoassays for benzoylphenylurea insecticides. J. Agric. Food Chem. 32 6 (1984) 1294-1301
16. Oubiña A., Barceló D., and Marco M.P. Competitor Design Influences Immunoassay Specificity: Development and Evaluation of an Enzyme Linked ImmunoSorbent Assay for 2,4-Dinitrophenol. Anal. Chim. Acta 387 (1999) 266-279
17. WADA, Minimum Required Perdormance Limits for Detection of Prohibited Substances, World Anti-doping Agency, 2004.